JP2023520703A5 - - Google Patents
Info
- Publication number
- JP2023520703A5 JP2023520703A5 JP2022560329A JP2022560329A JP2023520703A5 JP 2023520703 A5 JP2023520703 A5 JP 2023520703A5 JP 2022560329 A JP2022560329 A JP 2022560329A JP 2022560329 A JP2022560329 A JP 2022560329A JP 2023520703 A5 JP2023520703 A5 JP 2023520703A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- sialic acid
- composition
- approximately
- daily dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003477P | 2020-04-01 | 2020-04-01 | |
| US63/003,477 | 2020-04-01 | ||
| PCT/IB2021/000200 WO2021198774A1 (en) | 2020-04-01 | 2021-03-31 | Sialic acid compositions for use in inhibiting and treating coronavirus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023520703A JP2023520703A (ja) | 2023-05-18 |
| JP2023520703A5 true JP2023520703A5 (https=) | 2024-04-09 |
Family
ID=76250375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560329A Pending JP2023520703A (ja) | 2020-04-01 | 2021-03-31 | コロナウイルス感染症の防止および治療における使用のためのシアル酸組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11813271B2 (https=) |
| EP (1) | EP4125926A1 (https=) |
| JP (1) | JP2023520703A (https=) |
| KR (1) | KR20220161413A (https=) |
| CN (1) | CN115461057A (https=) |
| AU (1) | AU2021247584B2 (https=) |
| BR (1) | BR112022019685A2 (https=) |
| CA (1) | CA3173633A1 (https=) |
| WO (1) | WO2021198774A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230226088A1 (en) * | 2020-06-09 | 2023-07-20 | The Texas A&M University System | Therapeutics for treatment of covid-19 symptoms |
| WO2023104402A1 (en) | 2021-12-09 | 2023-06-15 | Frieslandcampina Nederland B.V. | Milk fraction that inhibits covid-19 infection |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976573A (en) | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
| EP2364139A2 (en) * | 2008-11-10 | 2011-09-14 | Life Science Nutrition AS | Ngna compositions and methods of use |
| AU2010315024B2 (en) * | 2009-11-06 | 2015-02-12 | Nexbio, Inc. | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
| CN111787925A (zh) * | 2017-10-11 | 2020-10-16 | 生命科学股份有限公司 | N-乙酰神经氨酸组合物和使用方法 |
| CN111481560A (zh) * | 2020-04-23 | 2020-08-04 | 菌维他(北京)医疗科技有限公司 | 唾液酸及衍生物在制备防治冠状病毒疾病的药品中的应用 |
| CN111658631A (zh) | 2020-06-11 | 2020-09-15 | 广东盛普生命科技有限公司 | 没食子酸及其衍生物和结构类似物在制备抗冠状病毒药物方面的应用 |
-
2021
- 2021-03-31 AU AU2021247584A patent/AU2021247584B2/en active Active
- 2021-03-31 CA CA3173633A patent/CA3173633A1/en active Pending
- 2021-03-31 US US17/916,104 patent/US11813271B2/en active Active
- 2021-03-31 WO PCT/IB2021/000200 patent/WO2021198774A1/en not_active Ceased
- 2021-03-31 CN CN202180027387.8A patent/CN115461057A/zh active Pending
- 2021-03-31 JP JP2022560329A patent/JP2023520703A/ja active Pending
- 2021-03-31 KR KR1020227037491A patent/KR20220161413A/ko active Pending
- 2021-03-31 EP EP21729616.9A patent/EP4125926A1/en active Pending
- 2021-03-31 BR BR112022019685A patent/BR112022019685A2/pt unknown
-
2023
- 2023-11-13 US US18/389,006 patent/US12390481B2/en active Active
-
2025
- 2025-08-18 US US19/302,949 patent/US20260083762A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100824075B1 (ko) | 일반 감기, 알레르기성 비염 및 호흡기에 관련된 감염 증상의 치료 방법 | |
| ES2988617T3 (es) | Norketotifeno para el tratamiento de la hipercitocinemia y las infecciones virales | |
| EA022840B1 (ru) | Фармацевтическая композиция, набор, их применение и способ профилактики и лечения симптома, состояния или заболевания, связанного с инфекцией вируса гриппа | |
| BRPI0506705A (pt) | composto de tiouréias azabenzofuran-substituìdas, composições farmacêuticas e seus usos | |
| JP2022539077A5 (https=) | ||
| JPWO2023054732A5 (https=) | ||
| JP2023520703A5 (https=) | ||
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| US6362225B1 (en) | Target therapies for treating common viral infections | |
| WO2021198940A1 (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 | |
| RU2008110933A (ru) | Применение амброксола для лечения риновирусных инфекций | |
| JP2019504040A (ja) | 中等度〜重度のインフルエンザの処置 | |
| KR900701278A (ko) | 바이러스 감염 치료용 담즙산 | |
| RU2762506C1 (ru) | Средство для аппликации полости рта и носа и способ его применения в составе комплексной терапии инфекционно-воспалительных заболеваний носовой и ротовой полости | |
| JP2025525990A5 (https=) | ||
| JPWO2012101846A1 (ja) | インフルエンザの治療剤または予防剤 | |
| US12171732B2 (en) | Compositions and use of N-chlorotaurine for treatment and prevention of respiratory infections | |
| JP2002030000A (ja) | 風邪根本治療法 | |
| RU2071773C1 (ru) | Лекарственное средство для лечения синдромов приобретенного иммунодефицита, в том числе вич-обусловленных | |
| CN102670684A (zh) | 白薇总皂苷的应用 | |
| SU923028A1 (ru) | Противовирусное средство бонафтон | |
| US4073928A (en) | Therapeutic treatment for viral regional ileitis infection | |
| RU95106997A (ru) | Лекарственное средство для лечения инфекционных заболеваний животных и способы лечения инфекционных заболеваний животных | |
| JP2022541021A (ja) | 神経変性障害を治療するためのベンゾエート含有組成物の使用 | |
| CN111603480A (zh) | 一种洗鼻剂 |